Ameriprise Financial Inc Roivant Sciences Ltd. Transaction History
Ameriprise Financial Inc
- $415 Billion
- Q3 2025
A detailed history of Ameriprise Financial Inc transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Ameriprise Financial Inc holds 448,361 shares of ROIV stock, worth $9.1 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
448,361
Previous 463,169
3.2%
Holding current value
$9.1 Million
Previous $5.22 Million
29.97%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding ROIV
# of Institutions
397Shares Held
464MCall Options Held
6.03MPut Options Held
2.52M-
Morgan Stanley New York, NY44.3MShares$899 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA42.1MShares$853 Million0.01% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X040.3MShares$818 Million4.61% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$718 Million0.01% of portfolio
-
Qvt Financial LP New York, NY29.4MShares$596 Million36.4% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $14.3B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...